Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents.
Fms-like tyrosine kinase 3 ligand stimulation induces MLL-rearranged leukemia cells into quiescence resistant to antileukemic agents. Cancer Res. 2007 Oct 15; 67(20):9852-61.
View in:
PubMed
subject areas
Apoptosis
Bone Marrow Cells
Cell Cycle
Cell Growth Processes
Cell Line, Tumor
Child, Preschool
Cyclin-Dependent Kinase Inhibitor p27
Dose-Response Relationship, Drug
Female
fms-Like Tyrosine Kinase 3
Gene Rearrangement
Histone-Lysine N-Methyltransferase
Humans
Infant
Infant, Newborn
Intracellular Signaling Peptides and Proteins
Male
Membrane Proteins
Mitogen-Activated Protein Kinases
Myeloid-Lymphoid Leukemia Protein
Phosphorylation
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Proto-Oncogene Proteins c-akt
STAT5 Transcription Factor
Stromal Cells
Up-Regulation
authors with profiles
Atsushi Nemoto